Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 25, Issue 9, Pages 1836-1845
Publisher
Oxford University Press (OUP)
Online
2016-03-05
DOI
10.1093/hmg/ddw057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling
- (2015) Joseph M Foster et al. BMC Medical Genomics
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
- (2015) Samuel A. Wells et al. THYROID
- Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
- (2015) M. Jafri et al. Cancer Discovery
- Inhibition of RET Increases the Efficacy of Antiestrogen and Is a Novel Treatment Strategy for Luminal Breast Cancer
- (2014) P. M. Spanheimer et al. CLINICAL CANCER RESEARCH
- Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes
- (2014) E. R. Maher CLINICAL MEDICINE
- Realizing the promise of cancer predisposition genes
- (2014) Nazneen Rahman NATURE
- Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer
- (2013) Valentina De Falco et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma: An Update
- (2013) Samuel A. Wells et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations inRETandRAS
- (2012) Nishant Agrawal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- RET in breast cancer: functional and therapeutic implications
- (2011) Andrea Morandi et al. TRENDS IN MOLECULAR MEDICINE
- Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes
- (2010) Cristina Romei et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Multiple endocrine neoplasia type 2RETprotooncogene database: Repository of MEN2-associatedRETsequence variation and reference for genotype/phenotype correlations
- (2009) Rebecca L. Margraf et al. HUMAN MUTATION
- A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer
- (2009) V. E. Smith et al. JOURNAL OF CELL SCIENCE
- The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ER Pathway in Breast Cancer
- (2008) A. Boulay et al. CANCER RESEARCH
- Loss of estrogen receptor β isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma
- (2008) Fumihiko Suzuki et al. CANCER SCIENCE
- The emerging landscape of breast cancer susceptibility
- (2007) Michael R Stratton et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now